Cost and research cuts across biotech and pharma are affecting some of the contracting companies that rely on the industry.
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...
Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...
Marinus Pharmaceuticals is reducing its workforce again and taking other measures to reduce costs after its ...
Zai Lab released Phase 1a data Thursday morning as it attempts to compete with a recently approved Amgen drug. The program, ...
Precision Biosciences has received clearance from regulators in the Eastern European country of Moldova to begin a human ...
GSK is presenting its case for broader use of its RSV vaccine with new data from a pair of studies in younger adults with ...
Novo Nordisk is continuing its crusade against compounded versions of its blockbuster weight loss drugs by petitioning the ...
Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...
More people are now advised to get a pneumococcal vaccine if they haven’t already, as CDC advisors recommended the shots for ...
The promise of a one-and-done CRISPR infusion is beginning to look more real than ever. On Thursday, Intellia ...
Plus, news about Interius BioTherapeutics, Hope Medicine, PMV Pharmaceuticals, Epitopea, Alyssum Therapeutics and a new dementia trial accelerator in the UK: Bayer exercises option to develop heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback